Pharmacy Times
JULY 31, 2024
Pharmacies can adapt by embracing digital self-service options to better engage with patients, meet increasing consumer demand, and enhance revenue streams.
Drug Topics
JULY 30, 2024
CVS Caremark and the State of Illinois settled a lawsuit due to the company’s failure to pay contracted rebates.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
AUGUST 2, 2024
As AI tools move from hype to a daily reality at pharma companies, here are the insights users are gaining.
STAT
AUGUST 2, 2024
Where and when the Covid-19 pandemic began — in Wuhan, China in late 2019 — is well known. How it began is a matter of heated controversy. There are two competing hypotheses, one of which is hindering the process of scientific discovery and could hold back the development of vaccines and other antiviral agents in the U.S. The zoonosis hypothesis proposes that SARS-CoV-2, the virus that causes Covid-19, was naturally transmitted from an animal to one or more humans in a so-called we
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
AUGUST 2, 2024
The experimental drug successfully reduced levels of SIV, the nonhuman primate equivalent of HIV, in the brain.
Drug Topics
AUGUST 2, 2024
The technology from Diakonos Oncology initiates a natural immune response that targets and eliminates cancer cells by activating cytotoxic TH1 cell signaling pathways.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
AUGUST 1, 2024
Malaria is one of our most ancient foes — and one of the wiliest. Caused by parasites that certain mosquitoes spread through their bites, malaria overwhelms us, establishing an infection before we can put up a fight. It can go on to destroy red blood cells, batter organs, and even damage the brain.
Pharmacy Times
JULY 29, 2024
Early identification of monoclonal gammopathy of undetermined significance leads to more efficacious disease monitoring and intervention.
Drug Topics
AUGUST 1, 2024
Pharmacists should be knowledgeable about the symptoms of chemical peel irritation to effectively advise patients.
PharmaVoice
JULY 31, 2024
The U.S. government will demand payment from Big Pharma to make up for dozens of drugs with prices that rose faster than the rate of inflation.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
AUGUST 2, 2024
Contract disputes between hospitals and health plans have become routine, but they tend to be local , affecting a handful of hospitals and the people in the surrounding communities. This latest one is different. It involves the country’s biggest private health insurer, UnitedHealthcare, and its biggest hospital chain, HCA Healthcare. If they can’t strike a deal on prices by Sept. 1, 38 hospitals and their affiliated physician groups and surgery centers across four states — T
Pharmacy Times
JULY 31, 2024
The findings indicate that zoster vaccine recombinant reduced dementia risk by 17% in an analysis of over 200,000 patients.
Drug Topics
JULY 29, 2024
Check out this list of our top 10 most read stories from July 2024.
PharmaVoice
JULY 29, 2024
A brain-on-a-chip developer says better preclinical modeling could help move the needle.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
JULY 31, 2024
Mount Sinai, a leading hospital network in New York City, has mounted an extraordinary behind-the-scenes campaign to blunt the fallout over revelations about its controversial research project in which brain biopsies are taken from patients undergoing deep brain stimulation, STAT has learned. That has included not only enlisting its own patients to defend the research but also seeking to stop a professional society of neurosurgeons from issuing a statement that could have jeopardized the researc
Pharmacy Times
JULY 29, 2024
Benzgalantamine (Zunveyl; Alpha Cognition) is a cholinesterase inhibitor indicated for the treatment of mild-to-moderate dementia in adults.
Drug Topics
JULY 31, 2024
Catch up on important immunization news from the month of July.
Fierce Healthcare
JULY 31, 2024
Humana affirmed its guidance for the year as it continues to face headwinds in the Medicare Advantage (MA) space. | Humana affirmed its guidance for the year as it continues to face headwinds in the Medicare Advantage space.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
JULY 31, 2024
Untreated vision loss and high LDL cholesterol have been added as two new potentially modifiable risk factors for dementia in a report released Wednesday by the Lancet Commission. These new additions join 12 other risk factors outlined by the commission, affiliated with University College London, in previous reports on dementia prevention, intervention, and care in 2017 and 2020.
Pharmacy Times
AUGUST 2, 2024
Dolutegravir/lamivudine was non-inferior to bictegravir/emtricitabine/tenofovir alafenamide fumarate, meeting the study’s primary end point.
Drug Topics
AUGUST 1, 2024
In 3 Phase 3 trials, elinzanetant reduced the frequency and severity of moderate to severe vasomotor symptoms, and improved sleep disturbances.
Fierce Healthcare
JULY 30, 2024
The U.S. healthcare system remains complex and inaccessible, leaving many seniors feeling uninformed, according to a new survey from digital health company DUOS. | Seniors are growing more comfortable with technology, but many still don't understand key differences between major health programs.
STAT
JULY 29, 2024
Bird flu snapshot: This is the latest installment in a series of regular updates on the H5N1 flu outbreak in dairy cows that STAT is publishing on Monday mornings. To read future updates, you can also subscribe to STAT’s Morning Rounds newsletter. A network of nascent vaccine manufacturers in low- and middle-income countries will soon start preliminary work to develop messenger RNA vaccines targeting the H5N1 bird flu virus, an effort that could speed production during a pandemic, should
Pharmacy Times
AUGUST 2, 2024
In an analysis of 16 immunocompromised patients with COVID-19, intravenous immunoglobulin was effective and associated with clinical cure.
Drug Topics
JULY 31, 2024
The investigational oral, selective NaV1.8 pain signal inhibitor from Vertex Pharmaceuticals demonstrated a favorable benefit/risk profile in 3 phase 3 trials.
Fierce Healthcare
JULY 30, 2024
Ochsner Health is going all-in on ambient AI voice technology for its thousands of doctors and has inked an enterprise agreement to roll out DeepScribe's technology across its health system. | Ochsner Health inked an enterprise-wide agreement with DeepScribe to roll out its AI medical scribe across its 46-hospital system for 4,700 providers.
STAT
JULY 29, 2024
The Food and Drug Administration on Monday approved a blood test intended to detect colon cancer, a product many experts hope will help catch cases of the disease early enough so that they can be more easily treated. The test, called Shield and made by Guardant Health, a Palo Alto, Calif.-based biotech firm, comes with a drawback: It is not as good as a colonoscopy and other tests at detecting precancerous or early stage cancers.
Pharmacy Times
AUGUST 2, 2024
The CDC says that even if travel is less than 2 weeks away, unvaccinated individuals should still receive a dose of the measles, mumps, and rubella vaccine for protection against the disease.
Drug Topics
JULY 29, 2024
Researchers analyzed the prominence of opioid and methadone prescriptions for hospitalized newborns with substantial morbidities.
Fierce Pharma
AUGUST 2, 2024
Adaptimmune has won accelerated FDA approval | Adaptimmune has won accelerated FDA approval for Tecelra (afami-cel), a treatment for metastatic or unresectable synovial sarcoma which becomes the first engineered cell therapy for a solid tumor and the first new treatment in the indication in more than a decade.
STAT
JULY 29, 2024
New blood tests could help doctors diagnose Alzheimer’s disease faster and more accurately, researchers reported Sunday – but some appear to work far better than others. It’s tricky to tell if memory problems are caused by Alzheimer’s. That requires confirming one of the disease’s hallmark signs — buildup of a sticky protein called beta-amyloid — with a hard-to-get brain scan or uncomfortable spinal tap.
Pharmacy Times
JULY 30, 2024
Polycystic ovary syndrome (PCOS) is closely associated with an increased risk of cardiovascular disease.
Drug Topics
JULY 29, 2024
A roundtable session discussed the real-world implications of applying Direct and Indirect Remuneration (DIR) fees at the point of sale rather than through retroactive clawback.
Expert insights. Personalized for you.
139 
Let's personalize your content